Sanofi SA vs Verizon Communications Inc — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Verizon Communications Inc trades at $43.73 (market cap $181.64B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.51%). Which is the better fit depends on your goals.
| SNY | VZ | |
|---|---|---|
Market Cap | $104.83B | $181.64B |
Sector | Health | Media |
52-Week High | $52.34 | $51.38 |
52-Week Low | $41.33 | $38.40 |
Enterprise Value | $121.32B | $369.14B |
Dividend Yield | 5.5% | 6.51% |
Volume | — | 22,584,735 |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →